MEA cancer diagnostics market highlights The MEA cancer diagnostics market generated a revenue of USD 4,429.0 million in 2023. In terms of segment, consumables was the largest revenue generating product in 2023. Asia Pacific is the fastest growing regional market and is projected to reach USD 35,952.3 million by 2030. Horizon Databook has segmented the Middle East & Africa cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030. Novel cancer tests, including liquid biopsy, are expensive, thus, there is a shortage of experienced professionals to perform these tests.
Source: The North Africa Journal November 08, 2024 14:57 UTC